Tag: Neurocrine Biosciences

February 27, 2020

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.
December 2, 2019

Neurocrine and Xenon to Develop Treatments for Epilepsy

The companies have announced a license and collaboration agreement to develop treatments for patients with epilepsy.
August 7, 2018

VIDEO — Life Science Update July 2018

July was a busy month for the life science space. Here the Investing News Network takes a look at what...
July 24, 2018

AbbVie Notches FDA Approval for Endometriosis Pain Treatment

The company says the drug has a projected availability date of August 2018 in US retail pharmacies. It is the...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...